1
|
Devos S, Bonnet F, Hessamfar M, Neau D, Vareil MO, Leleux O, Cazanave C, Rouanes N, Duffau P, Lazaro E, Dabis F, Wittkop L, Barger D, Blanco P, Bouchet S, Breilh D, Desjardin S, Gaborieau V, Gimbert A, Lacaze-Buzy L, Lacoste D, Lafon ME, Lawson-Ayayi S, Le Marec F, Le Moal G, Malvy D, Marchand L, Mercié P, Pellegrin I, Perrier A, Petrov-Sanchez V, Bernard N, Bronnimann D, Chaussade H, Dondia D, Faure I, Morlat P, Mériglier E, Paccalin F, Riebero E, Rivoisy C, Vandenhende MA, Barthod L, Dauchy FA, Desclaux A, Ducours M, Dutronc H, Duvignaud A, Leitao J, Lescure M, Nguyen D, Pistone T, Puges M, Wirth G, Courtault C, Camou F, Greib C, Pellegrin JL, Rivière E, Viallard JF, Imbert Y, Thierry-Mieg M, Rispal P, Caubet O, Ferrand H, Tchamgoué S, Farbos S, Wille H, Andre K, Caunegre L, Gerard Y, Osorio-Perez F, Chossat I, Iles G, Labasse-Depis M, Lacassin F, Barret A, Castan B, Koffi J, Saunier A, Zabbe JB, Dumondin G, Beraud G, Catroux M, Garcia M, Giraud V, Martellosio JP, Roblot F, Pasdeloup T, Riché A, Grosset M, Males S, Ngo Bell C, Carpentier C, Tumiotto C, Miremeont-Salamé G, Arma D, Arnou G, Blaizeau MJ, Camps P, Decoin M, Delveaux S, Diarra F, Gabrea L, Lai WH, Lenaud E, Plainchamps D, Pougetoux A, Uwamaliya B, Zara K, Conte V, Gapillout M. Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV). BMC Infect Dis 2023; 23:16. [PMID: 36624391 PMCID: PMC9830769 DOI: 10.1186/s12879-022-07963-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 12/21/2022] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND To evaluate drug use (alcohol, tobacco, cannabis and other drugs) and its association with mean CD4/CD8 T cell count ratio, a marker of chronic inflammation, in virally suppressed people living with HIV-1 (PLWH) in Nouvelle Aquitaine, France. METHODS A multi-centric, cross-sectional analysis was conducted in 2018-19 in the QuAliV study-ANRS CO3 AQUIVIH-NA cohort. Tobacco, alcohol, cannabis, and other drug use (poppers, cocaine, amphetamines, synthetic cathinones, GHB/GBL) were self-reported. CD4 and CD8 T cell counts and viral load measures, ± 2 years of self-report, and other characteristics were abstracted from medical records. Univariable and multivariable linear regression models, adjusted for age, sex, HIV risk group, time since HIV diagnosis, and other drug use were fit for each drug and most recent CD4/CD8 ratio. RESULTS 660 PLWH, aged 54.7 ± 11.2, were included. 47.7% [315/660] had a CD4/CD8 ratio of < 1. Their mean CD4/CD8 ratio was 1.1 ± 0.6. 35% smoked; ~ 40% were considered to be hazardous drinkers or have alcohol use disorder; 19.9% used cannabis and 11.9% other drugs. Chemsex-associated drug users' CD4/CD8 ratio was on average 0.226 (95% confidence interval [95% CI] - 0.383, - 0.070) lower than that of non-users in univariable analysis (p = 0.005) and 0.165 lower [95% CI - 0.343, 0.012] in multivariable analysis (p = 0.068). CONCLUSIONS Mean differences in CD4/CD8 ratio were not significantly different in tobacco, alcohol and cannabis users compared to non-users. However, Chemsex-associated drug users may represent a population at risk of chronic inflammation, the specific determinants of which merit further investigation. TRIAL REGISTRATION NUMBER NCT03296202.
Collapse
Affiliation(s)
- Sophie Devos
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,grid.42399.350000 0004 0593 7118CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 1 Rue Jean Burguet, 33000 Bordeaux, France
| | - Fabrice Bonnet
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,grid.42399.350000 0004 0593 7118CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, 1 Rue Jean Burguet, 33000 Bordeaux, France ,grid.7429.80000000121866389Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-P 1401, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France
| | - Mojgan Hessamfar
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,grid.42399.350000 0004 0593 7118CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 1 Rue Jean Burguet, 33000 Bordeaux, France ,grid.42399.350000 0004 0593 7118CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, 1 Rue Jean Burguet, 33000 Bordeaux, France
| | - Didier Neau
- grid.42399.350000 0004 0593 7118CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, Pl. Amélie Raba Léon, U121933000 Bordeaux, France
| | - Marc-Olivier Vareil
- grid.418076.c0000 0001 0226 3611Centre Hospitalier de la Côte Basque, Service de Maladies Infectieuses, 13 Avenue de l’interne Jacques Loëb, BP 8, 64109 Bayonne Cedex, France
| | - Olivier Leleux
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-P 1401, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France
| | - Charles Cazanave
- grid.42399.350000 0004 0593 7118CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, Pl. Amélie Raba Léon, U121933000 Bordeaux, France
| | - Nicolas Rouanes
- Centre Hospitalier de Périgueux, Service de Médecine Polyvalente, 80 Av. Georges Pompidou, 22400 Périgueux, France
| | - Pierre Duffau
- grid.42399.350000 0004 0593 7118CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, 1 Rue Jean Burguet, 33000 Bordeaux, France ,grid.4444.00000 0001 2112 9282Univ. Bordeaux, Department of Immunology, CNRS, ImmunoConcEpT, UMR 5164, 33000 Bordeaux, France
| | - Estibaliz Lazaro
- grid.42399.350000 0004 0593 7118CHU de Bordeaux, Service de Médecine Interne, 1 Avenue de Magellan, 33600 Pessac, France
| | - François Dabis
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,grid.42399.350000 0004 0593 7118CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 1 Rue Jean Burguet, 33000 Bordeaux, France
| | - Linda Wittkop
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,grid.7429.80000000121866389Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-P 1401, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,Univ. Bordeaux, INSERM, INRIA, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France ,grid.508062.90000 0004 8511 8605CHU de Bordeaux, Service d’information médicale, INSERM, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France
| | - Diana Barger
- grid.7429.80000000121866389Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076 Bordeaux Cedex, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Blanc P, Bonnet F, Leleux O, Perrier A, Bessede E, Pereyre S, Cazanave C, Neau D, Vareil MO, Lazaro E, Duffau P, Saunier A, André K, Wittkop L, Vandenhende MA, Blanco P, Bonnet F, Bouchet S, Breilh D, Cazanave C, Desjardin S, Gaborieau V, Gimbert A, Hessamfar M, Lacaze-Buzy L, Lacoste D, Lafon ME, Lawson-Ayayi S, Lazaro E, Leleux O, Le Marec F, Le Moal G, Malvy D, Marchand L, Mercié P, Neau D, Pellegrin I, Perrier A, Petrov-Sanchez V, Vareil MO, Wittkop L, Bernard N, Bonnet F, Bronnimann D, Chaussade H, Dondia D, Duffau P, Faure I, Hessamfar M, Mercié P, Morlat P, Mériglier E, Paccalin F, Riebero E, Rivoisy C, Vandenhende MA, Barthod L, Cazanave C, Dauchy FA, Desclaux A, Ducours M, Dutronc H, Duvignaud A, Leitao J, Lescure M, Neau D, Nguyen D, Malvy D, Pistone T, Puges M, Wirth G, Courtault C, Camou F, Greib C, Lazaro E, Pellegrin JL, Rivière E, Viallard JF, Imbert Y, Thierry-Mieg M, Rispal P, Caubet O, Ferrand H, Tchamgoué S, Farbos S, Vareil MO, Wille H, Andre K, Caunegre L, Gerard Y, Osorio-Perez F, Chossat I, Iles G, Gerard Y, Labasse-Depis M, Lacassin F, Barret A, Courtault C, Castan B, Koffi J, Rouanes N, Saunier A, Zabbe JB, Dumondin G, Gaborieau V, Gerard Y, Beraud G, Le Moal G, Catroux M, Garcia M, Giraud V, Martellosio JP, Roblot F, Pasdeloup T, Riché A, Grosset M, Males S, Bell CN, Pasdeloup T, Pasdeloup T, Blanco P, Pellegrin I, Carpentier C, Pellegrin I, Bellecave P, Lafon ME, Tumiotto C, Bouchet S, Breilh D, Miremeont-Salamé G, Arma D, Arnou G, Blaizeau MJ, Camps P, Decoin M, Delveaux S, Diarra F, Gabrea L, Lawson-Ayayi S, Lenaud E, Plainchamps D, Pougetoux A, Uwamaliya B, Zara K, Conte V, Gapillout M, Leleux O, Perrier A, Peyrouny-Mazeau A. Severe bacterial non-AIDS infections in persons with HIV: the epidemiology and evolution of antibiotic resistance over an 18-year period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine cohort. Clin Infect Dis 2023; 76:1814-1821. [PMID: 36610063 DOI: 10.1093/cid/ciac978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 12/19/2022] [Accepted: 12/27/2022] [Indexed: 01/09/2023] Open
Abstract
BACKGROUND Severe non-AIDS bacterial infections (SBIs) are one of the leading causes of hospital admissions among persons with HIV (PWH) in regions with high ART coverage. METHODS This large prospective cohort study of PWH examined the types of infections, bacterial documentation, and evolution of antibiotic resistance among PWH hospitalized with SBIs over an 18-year period. RESULTS Between 2000 and 2017, 459 PWH had at least one SBI with bacterial documentation. Among the 847 SBIs, there were 280 cases of bacteremia, 269 cases of pneumonia, and 240 urinary tract infections. The 1025 isolated bacteria included Enterobacteriaceae (n = 394; mainly Escherichia coli), Staphylococcus aureus (n = 153) and Streptococcus pneumoniae (n = 82). The proportion of S. pneumoniae as the causative agent in pneumonia and bacteremia decreased sharply over time, from 34% to 8% and from 21 to 3%, respectively.The overall antibiotic resistance of S. aureus and S. pneumoniae decreased progressively but it increased for Enterobacteriaceae (from 24% to 48% for amoxicillin-clavulanate, from 4 to 18% for cefotaxime, and from 5% to 27% for ciprofloxacin). Cotrimoxazole prophylaxis was associated with higher nonsusceptibility of S. pneumoniae to amoxicillin and erythromycin, higher nonsusceptibility of Enterobacteriaceae to beta-lactams and fluoroquinolones, and a higher risk of extended-spectrum β-lactamase producing Enterobacteriaceae. CONCLUSIONS The bacterial resistance pattern among PWH between 2014 and 2017 was broadly similar to that in the general population, with the exception of a higher resistance profile of Enterobacteriaceae to fluoroquinolones. The use of cotrimoxazole as prophylaxis was associated with an increased risk of antibiotic resistance.
Collapse
Affiliation(s)
- Peggy Blanc
- Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, F-33000 Bordeaux, France
| | - Fabrice Bonnet
- Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, F-33000 Bordeaux, France.,Université de Bordeaux, INSERM, BPH, U1219, F-33000 Bordeaux, France
| | - Olivier Leleux
- Université de Bordeaux, INSERM, BPH, U1219, F-33000 Bordeaux, France
| | - Adélaïde Perrier
- Université de Bordeaux, INSERM, BPH, U1219, F-33000 Bordeaux, France
| | - Emilie Bessede
- Centre Hospitalier Universitaire de Bordeaux, Laboratoire de Bactériologie, Hôpital Pellegrin, F-33000 Bordeaux, France
| | - Sabine Pereyre
- Centre Hospitalier Universitaire de Bordeaux, Laboratoire de Bactériologie, Hôpital Pellegrin, F-33000 Bordeaux, France.,Université de Bordeaux, CNRS, UMR 5234 Fundamental Microbiology and Pathogenicity, F-33000 Bordeaux, France
| | - Charles Cazanave
- Centre Hospitalier Universitaire de Bordeaux, Service des maladies Infectieuses et Tropicales, Hôpital Pellegrin, F-33000 Bordeaux, France
| | - Didier Neau
- Centre Hospitalier Universitaire de Bordeaux, Service des maladies Infectieuses et Tropicales, Hôpital Pellegrin, F-33000 Bordeaux, France
| | - Marc-Olivier Vareil
- Centre Hospitalier de la Côte Basque, Service de Maladies Infectieuses, F-64109 Bayonne, France
| | - Estibaliz Lazaro
- Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Interne, Hôpital du Haut-Lévêque, F-33600 Pessac, France
| | - Pierre Duffau
- Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Interne et Immunologie Clinique, Hôpital Saint-André, UMR 5164, F-33000 Bordeaux, France.,Université de Bordeaux, CNRS, Immuno ConcEpT, UMR 5164, F-33000 Bordeaux, France
| | - Aurélie Saunier
- Centre Hospitalier de Périgueux, Service de Médecine Interne, F-24000 Périgueux, France
| | - Katell André
- Centre Hospitalier de Dax, Service de Maladies Infectieuses, F-40100 Dax, France
| | - Linda Wittkop
- Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, F-33000, Bordeaux, France.,INRIA SISTM Team, F-33405, Talence, France.,Centre Hospitalier Universitaire de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, F-33000 Bordeaux, France
| | - Marie-Anne Vandenhende
- Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Interne, Hôpital Pellegrin, INSERM, Institut Bergonié, CIC-EC 1401, F-33000 Bordeaux, France.,Université de Bordeaux, INSERM, Institut Bergonié, CIC-EC 1401, F-33000 Bordeaux, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Pellissier G, Lolom I, Cairati N, Cherifi C, Amiel-Taieb C, Farbos S, Caillaud V, Gaudelus J, Gozlan C, Pinquier D, Gehanno JF, Luton D, Bouvet E, Abiteboul D. Maternity staff immunization coverage against pertussis and maternal vaccination practices: Results of a 2017 cross-sectional survey in five public maternity hospitals. Med Mal Infect 2019; 50:361-367. [PMID: 31375373 DOI: 10.1016/j.medmal.2019.07.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2018] [Revised: 04/01/2019] [Accepted: 07/12/2019] [Indexed: 11/19/2022]
Abstract
OBJECTIVES To conduct an audit of vaccination practices against pertussis in maternity wards to assess immunization practices targeting women, knowledge and awareness among health professionals and their involvement in the vaccination process, and to estimate their vaccine coverage. MATERIALS AND METHODS 2017 cross-sectional descriptive survey using a data collection sheet of immunization practices targeting women and an anonymous questionnaire for health professionals whose vaccine coverage had been documented by the occupational health service. RESULTS Five public maternity wards participated: one had a vaccination policy for women; 426 of 822 health professionals completed the questionnaire, 76% (from 50% of all residents to 83% of nurses) declared their vaccination status as up to date. Staff files in occupational health services showed that 69% of 822 health professionals received at least one vaccine booster during adulthood (57% less than 10 years before the survey); documented vaccination coverage rates ranged from 75% for residents to 91% for senior physicians. Occupational physicians and family physicians respectively performed 41% and 34% of vaccinations. While knowledge regarding vaccines was good, only 47% of health professionals declared prescribing them and 18% declared administering the anti-pertussis vaccine "often" or "very often". CONCLUSIONS Updated data is needed to confirm the reported increase as participating centers are not representative of all birth centers. The active role of health professionals in vaccination-based pertussis prevention needs to be reinforced.
Collapse
Affiliation(s)
- G Pellissier
- Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France.
| | - I Lolom
- Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France; Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| | - N Cairati
- Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France; Hôpital Beaujon AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France
| | - C Cherifi
- Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| | - C Amiel-Taieb
- Hôpital Beaujon AP-HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France
| | - S Farbos
- Centre Hospitalier de la Côte Basque, 13, avenue de l'Interne Jacques Loeb, 64100 Bayonne, France; Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France
| | - V Caillaud
- Centre Hospitalier de la Côte Basque, 13, avenue de l'Interne Jacques Loeb, 64100 Bayonne, France
| | - J Gaudelus
- Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France; Hôpital Jean-Verdier AP-HP, avenue du 14 juillet, 93140 Bondy, France
| | - C Gozlan
- Hôpital Jean-Verdier AP-HP, avenue du 14 juillet, 93140 Bondy, France
| | - D Pinquier
- Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France; CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France
| | - J F Gehanno
- CHU de Rouen, 37, boulevard Gambetta, 76000 Rouen, France
| | - D Luton
- Hôpital Bichat-Claude-Bernard AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| | - E Bouvet
- Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France; Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France
| | - D Abiteboul
- Groupe d'Étude sur le Risque d'Exposition des Soignants aux agents infectieux (GERES), UFR de Médecine Bichat, 16, rue Henri-Huchard, 75018 Paris, France; Sous-Groupe Professionnels de santé, Groupe Prévention de la Société Française de Pathologie Infectieuse de Langue Française, 21, rue de Beaurepaire, 75010 Paris, France
| |
Collapse
|
4
|
Valdes A, Cazanave C, Dabis F, Neau D, Lacoste D, Gaborieau V, Farbos S, Dworkin MS. Knowledge, behaviors, and attitudes of HIV-infected men about syphilis. Med Mal Infect 2017; 47:470-476. [PMID: 28943166 DOI: 10.1016/j.medmal.2017.07.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2016] [Revised: 11/30/2016] [Accepted: 07/27/2017] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To explore knowledge on syphilis, sexual behaviors, and attitudes in men living with HIV in southwestern France. PATIENTS AND METHODS In the ANRS CO3 Aquitaine Cohort of people living with HIV (PLHIV), a self-administered questionnaire was proposed to all male PLHIV attending one of the seven participating clinics between September 22 and October 24, 2014. The 15 questions explored patient knowledge about syphilis disease, attitudes, and behaviors during sexual intercourse. RESULTS Among 302 patients surveyed, 101 reported at least one episode of syphilis. A history of syphilis was associated with awareness that syphilis was on the rise in men who have sex with men (MSM) in the Aquitaine region (46% vs. 22%, P<0.0001). Knowledge that syphilis could be transmitted by oral sex was low in both patients with (37%) and without (20%) a history of syphilis (P=0.0045). Patients with a history of syphilis more often used recreational drugs (RR 1.6; P=0.0028). Among 160 patients who had sexual intercourse with a man in the past 12 months, 23% reported using condoms for oral intercourse and 80% reported using condoms for anal intercourse. Sixty-two per cent of MSM declared being ready to change their practice if informed about the rise in syphilis. CONCLUSIONS This survey revealed important information gaps in PLHIV about syphilis and related behavior. The reported receptiveness of this population to behavioral change may help inform educational interventions.
Collapse
Affiliation(s)
- A Valdes
- Université de Bordeaux, Inserm U1219, ISPED, 33076 Bordeaux, France; Université de Bordeaux, ISPED, 33076 Bordeaux, France; COREVIH Aquitaine, 33076 Bordeaux, France
| | - C Cazanave
- COREVIH Aquitaine, 33076 Bordeaux, France; Service des maladies infectieuses et tropicales, hôpital Pellegrin, CHU de Bordeaux, 33076 Bordeaux, France; Université de Bordeaux, USC EA 3671, infections humaines à mycoplasmes et à chlamydiae, 33076 Bordeaux, France; Inra, USC EA3671, infections humaines à mycoplasmes et à chlamydiae, 33076 Bordeaux, France.
| | - F Dabis
- Université de Bordeaux, Inserm U1219, ISPED, 33076 Bordeaux, France; Université de Bordeaux, ISPED, 33076 Bordeaux, France; COREVIH Aquitaine, 33076 Bordeaux, France
| | - D Neau
- COREVIH Aquitaine, 33076 Bordeaux, France; Service des maladies infectieuses et tropicales, hôpital Pellegrin, CHU de Bordeaux, 33076 Bordeaux, France
| | - D Lacoste
- COREVIH Aquitaine, 33076 Bordeaux, France; Service de médecine interne, hôpital Saint-André, CHU de Bordeaux, 33075 Bordeaux, France
| | - V Gaborieau
- Service de médecine, centre hospitalier de Pau, 64000 Pau, France
| | - S Farbos
- Service de maladies infectieuses, centre hospitalier de la Côte-Basque, 64100 Bayonne, France
| | - M S Dworkin
- Université de Bordeaux, Inserm U1219, ISPED, 33076 Bordeaux, France; Université de Bordeaux, ISPED, 33076 Bordeaux, France; School of Public Health, University of Illinois, Chicago, United States
| | | |
Collapse
|
5
|
Rakotoarivelo RA, Raveloson HFR, Razafimahefa SH, Farbos S, Gemain MC, Bonnal F. [Brain abscess with Nocardia asteroides revealing lung adenocarcinoma]. Rev Pneumol Clin 2011; 67:329-330. [PMID: 22017956 DOI: 10.1016/j.pneumo.2011.01.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2010] [Revised: 11/28/2010] [Accepted: 01/10/2011] [Indexed: 05/31/2023]
|
6
|
de Pommerol M, Hessamfar M, Lawson-Ayayi S, Neau D, Geffard S, Farbos S, Uwamaliya B, Vandenhende MA, Pellegrin JL, Blancpain S, Dabis F, Morlat P. Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort. Int J STD AIDS 2011; 22:67-72. [DOI: 10.1258/ijsa.2010.010187] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Affiliation(s)
- M de Pommerol
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
| | - M Hessamfar
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
- Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire (CHU) de Bordeaux
| | - S Lawson-Ayayi
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
| | - D Neau
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
- Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire (CHU) de Bordeaux
- Université Victor Segalen Bordeaux 2, Bordeaux
| | - S Geffard
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
| | - S Farbos
- Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier de la Côte Basque
| | - B Uwamaliya
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
| | - M-A Vandenhende
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
- Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire (CHU) de Bordeaux
- Université Victor Segalen Bordeaux 2, Bordeaux
| | - J-L Pellegrin
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
- Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire (CHU) de Bordeaux
- Université Victor Segalen Bordeaux 2, Bordeaux
| | - S Blancpain
- Service de Gynécologie Médicale et Chirurgicale, CHU de Bordeaux, Bordeaux, France
| | - F Dabis
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
- Université Victor Segalen Bordeaux 2, Bordeaux
| | - P Morlat
- INSERM U897 and Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen Bordeaux 2
- Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH)
- Services de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire (CHU) de Bordeaux
- Université Victor Segalen Bordeaux 2, Bordeaux
| |
Collapse
|
7
|
Bruyand M, Geffard S, Lawson-Ayayi S, Dauchy F, Miremont-Salamé G, Greib C, Farbos S, Morlat P, Dabis F. Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008. J Int AIDS Soc 2010. [PMCID: PMC3113039 DOI: 10.1186/1758-2652-13-s4-p37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
8
|
Vandentorren S, Mercié P, Marimoutou C, Neau D, Malvy D, Farbos S, Dabis F. Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997. Eur J Epidemiol 2002; 17:7-10. [PMID: 11523579 DOI: 10.1023/a:1010972410865] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To describe trends in the evolution of causes of death in a cohort of HIV-infected patients before and after the introduction of highly active antiretroviral treatment (HAART). METHODS This descriptive study concerned all the patients of the Aquitaine cohort who died between 1995 and 1997. Causes of deaths were grouped into 13 'deaths due to an AIDS-defining underlying cause', and eight 'non AIDS' categories. Comparisons were performed between two comparable periods of 18 months, January 1995-June 1996 and July 1996-December 1997 to focus on changes introduced by the prescription of HAART in June 1996. RESULTS Five hundred and thirty-two deaths were notified in 36 months for a total of 3687 patients. The comparison between causes of deaths before and after June 1996 showed a significant difference between the two periods with a decreasing proportion of AIDS causes of death, from 82.7% to 72.2% (p = 0.007). CONCLUSION HAART treatment has reduced the number and percentage of deaths due to AIDS-related causes among persons who died with HIV infection in South-western France.
Collapse
Affiliation(s)
- S Vandentorren
- INSERM U330, Université Victor Segalen Bordeaux 2, France
| | | | | | | | | | | | | |
Collapse
|
9
|
Farbos S, Resnikoff S, Peyramaure F. Urbanisation and vitamin A deficiency in children: comparison between a traditional district and a new settlement in Mali. Eur J Epidemiol 2001; 16:1143-9. [PMID: 11484804 DOI: 10.1023/a:1010964029771] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVES The purpose of this study was to assess the vitamin A status of pre-school urban children and to compare the situation between a traditional district and a new settlement after two decades of intense urbanisation. SUBJECTS AND METHODS A cross-sectional stratified survey was carried out in Bamako, Mali, on a representative sample of children (aged 4-6 years). 532 children were involved from a traditional district and 453 from a new settlement (NS). The vitamin A status was assessed by: clinical indicators (ophthalmic examination), subclinical indicators (questionnaire looking for night blindness, impression cytology with transfer test (ICT), modified relative dose response test (MRDR), and a diet inquiry about vitamin A intakes. Acute malnutrition was assessed by a weight/height measure. RESULTS In both districts, all the clinical indicators were below the WHO criteria that define a public health problem. Both the ICT test, respectively 19 and 21% of abnormal tests, and the MRDR, 67.3 and 73.1% of tests > or = 0.06, indicated a subclinical vitamin A deficiency as defined by WHO thresholds. During the preceding week only four children in NS had consumed vitamin A-rich food less than seven times. No significant difference between the two districts was found either for clinical or subclinical indicators (p > 0.5). CONCLUSION Despite a rapid urbanisation, the vitamin A status of the children seemed to be rather homogeneous among the different districts. The population remained vulnerable with peripheral depletion and low hepatic stores of vitamin A. The urban children should be carefully monitored regarding vitamin A status.
Collapse
Affiliation(s)
- S Farbos
- Centre Hospitalier de la Côte Basque, Bayonne, France.
| | | | | |
Collapse
|
10
|
Marimoutou C, Chêne G, Mercié P, Neau D, Farbos S, Morlat P, Ceccaldi J, Dabis F. Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998. J Acquir Immune Defic Syndr 2001; 27:161-7. [PMID: 11404538 DOI: 10.1097/00126334-200106010-00011] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To describe the viroimmunologic response and its prognostic factors 6 months after initiating triple antiretroviral therapy in a cohort of HIV-1-infected patients. METHODS Positive virologic response during follow-up (VL+) was defined as plasma HIV RNA level <500 copies/ml and positive immunologic response (CD4+) as an increase of CD4+ count of at least 50 cells/mm3. Four categories of response were defined: VL+/CD4+; VL+/CD4-; VL-/CD4+ and VL-/CD4-. Prognostic factors were studied through a polytomous logistic regression (VL-/CD4-, as reference). RESULTS Baseline characteristics of the 478 studied patients were: 22% at AIDS stage, 77% pretreated, median CD4+ cell count 195/mm3 and HIV RNA level 4.42 log. At 6 months 37.5% were VL+/CD4+; 15.7% VL+/CD4-; 23.8% VL-/CD4+ and 23.0% VL-/CD4-. Baseline HIV RNA level was associated to a higher risk of VL-/CD4+ response. More advanced age was associated with a higher risk of isolated immunologic failure (VL+/CD4-), whereas pretreatment and saquinavir therapy were associated with a lower frequency of positive virologic response independently of immunologic response. CONCLUSION HIV-RNA level, pretreatment, and saquinavir therapy were already known to be linked to therapeutic response. Based on our results, a high baseline HIV-RNA level is associated with isolated immunologic response; moreover, age should be of importance in treatment decision.
Collapse
Affiliation(s)
- C Marimoutou
- GECSA-INSERM Unité 330, Université Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Thiébaut R, Daucourt V, Mercié P, Ekouévi DK, Malvy D, Morlat P, Dupon M, Neau D, Farbos S, Marimoutou C, Dabis F. Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine. Clin Infect Dis 2000; 31:1482-7. [PMID: 11096016 DOI: 10.1086/317477] [Citation(s) in RCA: 128] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2000] [Revised: 05/08/2000] [Indexed: 11/03/2022] Open
Abstract
The objective of this study was to estimate the prevalence of and risk factors for clinical lipodystrophy (LD) and metabolic disorders in human immunodeficiency virus (HIV) type 1-infected patients. A cross-sectional survey of the Aquitaine Cohort was performed in January 1999. The clinical diagnosis of LD was categorized as fat wasting (FW), peripheral fat accumulation (FA), and mixed syndromes (MS). Of the 581 patients studied, 61% were treated with protease inhibitors. The overall prevalence of LD was 38% (95% confidence interval [CI], 32-42): prevalence of FW was 16% (95% CI, 13-18); of FA, 12% (95% CI, 10-15); and of MS, 10% (95% CI, 8-13). The prevalences of metabolic abnormalities were 49% (95% CI, 44-53) for lipid disorders and 20% (95% CI, 17-23), for glucose disorders. Factors associated with LD were age (for FW and MS), male sex (for FW), AIDS stage (for MS), body mass index (for FW and FA), waist-to-hip ratio (for FA and MS), and duration of antiretroviral treatment (for FW).
Collapse
Affiliation(s)
- R Thiébaut
- Unité INSERM 330, Institut de Santé Publique, d'Epidémiologie et de Développement, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Farbos S, Resnikoff S, Peyramaure F. Urbanisation et déficit en vitamine A. Rev Med Interne 1999. [DOI: 10.1016/s0248-8663(99)80417-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
13
|
Nouts C, Salort Y, Dupon M, Marimoutou C, Farbos S, Chêne G, Beylot J. Pronostic des patients infectés par le VIH pris en charge à un stade avancé de l'immunodépression. Rev Med Interne 1997. [DOI: 10.1016/s0248-8663(97)80342-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
14
|
Farbos S, Resnikoff S, Peyramaure F, Castan R. [Xerophthalmia. Identification of populations at intermediate risk]. Sante 1995; 5:159-161. [PMID: 7640898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
In developing countries, vitamin A deficiency (VAD) is a major contributor to child blindness and is associated with increased mortality. We assessed the vitamin A status of a Sahelien population and evaluated the correlation between the various criteria used to score xerophthalmia. The survey was carried out between June 1992 (the end of the dry season) using a representative sample of 906 children between the ages of 3 and 7 years in the district of Douentza. The population sample was selected by a two stage cluster sampling method (villages and then households). Vitamin A status was evaluated using clinical, histological and nutritional criteria. Clinical examination included testing for night blindness (XN), Bitot's spots (X1B) and corneal scars (XS). The Impression Cytology with Transfer (ICT) test described by Amedee-Manesme was used for histological analysis. Cases of follicular trachoma were recorded because of the possible influence of active trachoma on the findings of the ICT test. Nutritional status was determined by measuring the height for weight ratio according to the National Center for Health Statistics criteria. The prevalence of XN was 2.7% (1.6-3.7), significantly higher than the WHO threshold for a public health problem. The prevalence of X1B was 0.5% (0.1-1.2), and no corneal scars were detected. 31.7% of the children were suffering from malnutrition, but malnutrition did not correlate with any of the ophthalmological indicators of a public health problem. Among the 842 readable ICT tests, 265 were abnormal (31.4% of the total, 28.2-34.5). This incidence of abnormal results was unexpectedly low, in the light of the clinical results, and well below the threshold value of 50% suggested by Carlier.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- S Farbos
- Centre hospitalier de Côte Basque, Bayonne, France
| | | | | | | |
Collapse
|